DR. REDDY'S LABORATORIES-ADR (RDY) Stock Balance Sheet
USA - NYSE:RDY - US2561352038 - ADR
13.47 USD
+0.01 (+0.07%)
| MRQ (2025-9-30) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | 4.35B | 2.69B | 12.38B | |||
| Cash Equivalents | 9.91B | 2.51B | 2.60B | 2.93B | 2.31B | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 64.06B | 43.26B | 74.36B | 56.02B | 29.51B | |||
| Receivables | 97.75B | 110.70B | 98.83B | 87.99B | 78.08B | |||
| Inventories | 75.82B | 76.89B | 63.55B | 48.67B | 50.88B | |||
| Other Current Assets | 32.01B | 4.83B | 4.36B | 5.95B | 4.65B | |||
| Total Current Assets | 279.56B | 250.18B | 248.05B | 204.25B | 177.82B | |||
| Non-Current Assets | ||||||||
| PPE Net | 111.16B | 96.98B | 76.00B | 66.29B | 61.66B | |||
| Investments And Advances | 10.79B | 15.33B | 5.72B | 5.42B | 8.09B | |||
| Goodwill | 14.04B | 13.14B | 5.50B | 5.47B | 5.47B | |||
| Intangibles | 100.94B | 96.80B | 36.95B | 30.72B | 27.01B | |||
| Other Non-Current Assets | 23.53B | 19.17B | 11.74B | 7.79B | 13.56B | |||
| Total Non-Current Assets | 264.17B | 244.09B | 140.59B | 118.60B | 119.65B | |||
| TOTAL ASSETS | 543.73B | 494.27B | 388.64B | 322.85B | 297.47B | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 38.05B | 12.72B | 7.39B | 27.08B | |||
| Current Portion Of LT Debt. | 46.90B | 857.00M | 1.31B | 4.80B | 1.02B | |||
| Accrued Expenses | null | 30.41B | 29.71B | 28.02B | 24.04B | |||
| Accounts Payable | 35.32B | 26.48B | 26.14B | 22.68B | 22.66B | |||
| Other Current Liabilities | 68.82B | 34.55B | 26.00B | 22.82B | 22.86B | |||
| Total Current Liabilities | 151.04B | 130.34B | 95.88B | 85.72B | 97.66B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 11.64B | 7.86B | 5.99B | 1.28B | 5.75B | |||
| Deferred Taxes/Income | 14.79B | 14.04B | 841.00M | 760.00M | 14.00M | |||
| Other Non-Current Liabilities | 2.53B | 2.75B | 3.38B | 2.23B | 1.93B | |||
| Total Non-Current Liabilities | 32.55B | 28.43B | 10.21B | 4.27B | 7.69B | |||
| TOTAL LIABILITIES | 183.59B | 158.77B | 106.09B | 89.99B | 105.34B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 359.31B | 326.48B | 272.55B | 224.56B | 183.43B | |||
| Additional Paid In Capital | null | 8.55B | 8.19B | 7.11B | 6.70B | |||
| Minority Interest | 3.59B | 3.78B | null | null | null | |||
| Common Shares | 835.00M | 834.00M | 834.00M | 833.00M | 832.00M | |||
| Treasury Stock | null | -2.26B | -991.00M | -1.27B | -1.60B | |||
| Other Shareholders' Equity | null | 1.89B | 1.97B | 1.63B | 2.76B | |||
| Shares Outstanding | 831.94M | 831.43M | 832.07M | 830.21M | 829.22M | |||
| Tangible Book Value per Share | 294.4799 | 271.0975 | 288.3543 | 236.7199 | 192.3867 | |||
| Total Shareholders' Equity | 360.14B | 335.50B | 282.55B | 232.86B | 192.12B | |||
| TOTAL LIABILITIES AND EQUITY | 543.73B | 494.27B | 388.64B | 322.85B | 297.47B | |||
| Statistics | ||||||||
| Debt/Equity | 0.03 | 0.14 | 0.07 | 0.04 | 0.17 | |||
| Current Ratio | 1.85 | 1.92 | 2.59 | 2.38 | 1.82 | |||
| Return On Assets (ROA) | 10.62% | 11.44% | 14.35% | 13.96% | 7.34% | |||
| Return On Equity (ROE) | 16.03% | 16.86% | 19.74% | 19.36% | 11.36% | |||
| Return On Invested Capital (ROIC) | 13.03% | 13.26% | 16.08% | 16.44% | 11.83% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 16.05% | 14.96% | 21.50% | 21.67% | 13.77% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 25.11% | 21.64% | 26.40% | 26.92% | 16.52% | |||
All data in INR , ROIC based on taxRate of 0.24